ARTICLE | Company News
PharmAthene, U.S. Department of Health and Human Services infectious news
March 29, 2010 7:00 AM UTC
PharmAthene said that work has been suspended under its amended 2003 contract with HHS' Biomedical Advanced Research and Development Authority (BARDA) to develop the company's recombinant protective ...